Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people feel very little when they inject Wegovy. The pre-filled pen uses a fine, short needle, and the injection itself typically takes just a few seconds. Some people notice a mild sting or a brief sensation of pressure under the skin; others feel almost nothing at all. What you experience at the skin surface is quite different from what you may feel in the hours that follow — and both are worth understanding before your first dose. Wegovy (semaglutide) is a prescription-only medicine that a GPhC-registered prescriber must assess you for before it can be dispensed.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Wegovy pen is pre-set: you press it against the skin, press the button, and the needle inserts and retracts automatically. Most people are surprised by how brief the physical sensation is. The needle is fine-gauge and short, designed to reach the subcutaneous fat layer just beneath the skin rather than muscle, so there is no need to press hard or hold at an angle.
The most common descriptions are a small pinch, a faint pressure, or nothing in particular, and if that last one sounds familiar, our page on what it means when you didn't feel the Wegovy injection explains why that is more common than people expect. A mild sting during or just after the injection happens fairly often, especially at higher doses or when the liquid is cold straight from the fridge. Letting the pen sit at room temperature for ten to fifteen minutes first can reduce that sensation noticeably. Some people also notice a slight burning feeling that fades within a minute or so, this is normal and reflects the liquid dispersing under the skin.
If the site feels genuinely sore, develops a hard lump that doesn't resolve in a day or two, or shows spreading redness, that is worth mentioning to your prescriber. These reactions are uncommon but the NHS patient information for semaglutide covers what to watch for and when to seek advice, so that page is a practical first reference.
Wegovy is injected subcutaneously into the abdomen, thigh or upper arm, rotated with each weekly dose. The amount of sensation varies between sites. The abdomen (specifically the area two inches either side of the navel) tends to have slightly less sensation than the thigh, which has more nerve endings near the surface. The upper arm can be trickier to reach alone and may feel more sensitive if the muscle is accidentally engaged.
Rotating sites is recommended not just for comfort but to prevent a build-up of scar tissue that can affect how the medicine absorbs over time. If one spot consistently stings more, moving to a different area the following week often helps. Injecting into skin that is actively irritated, sunburned or has a bruise from last week's dose is worth avoiding for obvious reasons. Cleaning the area with an alcohol swab beforehand and letting it dry fully before injecting (damp skin stings more) is a small habit that makes a real difference.
Some patients find they barely register the process after the first few weeks once the routine becomes familiar, and our guide to the Wegovy injection covers what that routine looks like step by step. First-time injectors sometimes tense the muscle underneath without realising it, which makes things feel sharper than they need to be. Relax the area, sit comfortably, and take your time.
This is where many people's real questions sit. The needle sensation is brief. The after-effects of semaglutide itself can last longer and feel more significant, particularly in the first few weeks or after a dose increase.
Nausea is the most commonly reported post-injection experience, followed by reduced appetite, bloating, burping, and sometimes loose stools or constipation. These are not caused by the injection technique, they are pharmacological: semaglutide slows how quickly the stomach empties and acts on appetite centres in the brain. The NHS England guidance on weight-management injections notes that GI effects are typically most noticeable in the first days after starting or moving up a dose, and generally settle as the body adjusts.
Injecting in the evening (after dinner, before bed) is a strategy some people find useful because the peak of any nausea passes while they're asleep. Others prefer a Sunday morning so they have a quiet day to rest if needed. There's no single right answer; it depends on your routine. If you're not sure which suits you, it's the kind of question our prescribers answer during the consultation and aftercare check-ins. You can also find detail on unusual taste sensations after injecting, a less-discussed but real experience for some users.
For those who felt nothing at all and wondered whether the injection worked, that question comes up often enough to have its own answer. If you are curious whether you can feel the Wegovy needle and what it means if you cannot, that page covers it properly. The short version: not feeling it does not mean it didn't deliver.
Mild physical sensation at the injection site is not a reason to pause treatment. Neither is redness that fades within an hour or a small, soft lump under the skin that resolves in a day. These are normal local reactions documented in the clinical trial programme and listed in the Wegovy injection patient information, which sets out what to expect at each stage of treatment.
The reactions that warrant prompt medical attention are different in character: spreading redness or warmth that worsens over 24 hours, a lump that grows rather than shrinks, signs of an allergic reaction such as swelling of the face, lips or throat, or difficulty breathing. These are uncommon. Severe, persistent stomach pain that radiates towards the back (unrelated to the injection site) should always be assessed urgently as it may indicate pancreatitis, a rare but serious effect that the MHRA has highlighted in guidance for all GLP-1 medicines.
Yellow Card, the MHRA's reporting tool at yellowcard.mhra.gov.uk, exists for anyone who wants to report a suspected side effect, including unexpected injection-site reactions. It matters: real-world reports from patients directly inform MHRA safety reviews. If you're unsure whether what you're experiencing is normal, our aftercare team is available seven days a week and a prescriber can review your situation the same day.
Thinking about whether Wegovy could be right for you? If you would like to understand how it compares with other options, our overview of weight loss injections including Ozempic is a useful starting point, and you can check your eligibility with a free consultation, no waiting list, a real prescriber reviews your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.